氨基酸、有机酸、碱基核苷类化合物的双向色谱多相同步分析

30余种氨基酸、40余种非挥发性有机酸和20余种碱基核苷类化合物在一块薄层板上完成多相同步色谱分析；用紫外灯-吖啶试剂-镉茚三酮试剂实行组合显色定位分析。改善了尿液中非挥发性有机酸的溶剂萃取法，尿中三类化合物提取物的同步多相色谱分离效果良好。     

235例神经症患者就诊途径及心理分析

研究目的探讨神经症的就诊途径及心理治疗措施。研究方法分析研究对5例神经症患者的就诊途径、就诊心理、治疗方法和治疗效果。结果对住院治疗的对5例神经症进行分析研究，结果表明，正确的就诊途径，合理的治疗方法，使神经症治疗时间明显缩短，疗效显著提高，有效230例，占97.9％。结论本研究明确了就诊途径、治疗方法在神经症治疗中的重要作用，以及普及精神卫生知识的重要性，为神经症的防治工作提供了重要依据。     

Acetazolamide in hemodialysis patients: a rational use after ocular surgery.

Acetazolamide is a weak diuretic used to decrease production of aqueous humor in the eye. Hemodialysis patients undergoing ocular surgery may benefit from acetazolamide; however, no pharmacokinetic data are available for this group of patients. We report a patient who received acetazolamide 250 mg every 6 hours after ophthalmic surgery and developed reversible neurological side effects associated with very high plasma concentrations. Using pharmacokinetic analysis, we suggest an alternate administration of acetazolamide for end-stage renal patients.     

海风藤酚、甲基海风藤酚、海风藤醇A和海风藤醇B对兔血小板聚集的影响

海风藤酚、甲基海风藤酚、海风藤醇Ａ和海风藤醇Ｂ均有抑制血小板激活因子（ＰＡＦ）诱导的兔血小板聚集作用，ＩＣ_（５０）分别为１７．９、９．２、１４２．０、１４．０μｍｏｌ·Ｌ~（－１）。经阿司匹林（ＡＳＡ）、磷酸肌酸／磷酸肌酸激酶（ＣＰ／ＣＰＫ）预处理的兔洗涤血小板，甲基海风藤酚和海风藤醇Ｂ仍能抑制ＰＡＦ诱导的兔血小板聚集，ＩＣ_（５０）为９．０、１６．５μｍｏｌ·Ｌ~（－１）。同时，４种成分对于二磷酸腺苷（ＡＤＰ），花生四烯酸（ＡＡ）诱导的血小板聚集抑制作用较弱，海风藤Ｂ能使ＰＡＦ诱导血小板聚集量－效曲线平行右移，ＥＣ_（５０）由１．５９ｎｍｏｌ·Ｌ~（－１）升为２０．６ｎｍｏｌ·Ｌ~（－１）。结果表明：４种成分能选择性拮抗ＰＡＦ对兔血小板的聚集作用。     

Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting.

To determine the potential impact of recombinant human erythropoietin (EPO) therapy in patients undergoing autologous bone marrow transplantation (BMT) and colony-stimulating factor therapy, we assayed endogenous serum EPO levels and noted blood transfusion requirements in relapsed non-Hodgkin's lymphoma patients treated with high-dose chemo-radiation therapy and autologous BMT. Hematocrit and reticulocyte counts were determined daily, and hematocrit was maintained in the 25-30% range by transfusion according to criteria established by our hospital transfusion committee. EPO levels were measured by radioimmunoassay and were determined at baseline, throughout therapy, and 2 and 3 months after BMT. Serum EPO levels increased more than 25-fold above baseline in most subjects after initiating chemoradiation therapy. No correlation was noted between serum EPO and hematocrit, reticulocyte count or serum creatinine. Total red blood cell units transfused ranged from 4 to 15 (mean 7.7). Mean total donor exposures (red blood cell plus platelet units transfused) were 83.6 units (range 16-175). Serum EPO levels increased early in the course of preparation for autologous BMT and remained elevated for at least 2-3 weeks thereafter although at a lower level. Red blood cell transfusions were required despite very high EPO levels after BMT. Red cell transfusions, moreover, accounted for only 9.2% (69 of 746) of total donor exposures and only 5.8% (42 of 746) of donor exposures during the interval when pharmacologic doses of erythropoietin might be of benefit. In contrast to the potential benefit of colony-stimulating factors such as G-CSF and GM-CSF in BMT, our study suggests limited value for erythropoietin therapy in this setting.     

Migrating calcified enterolith and chronic anemia: an unusual case presentation of a Meckel's diverticulum.

Meckel's diverticulum is the most common congenital anomaly of the small intestine, occurring in about 2 % of the population. The most common complications associated with a Meckel's diverticulum include obstruction, bleeding, and inflammation (7, 9, 11, 18-20). The estimated lifetime risk of developing symptoms with a Meckel's diverticulum is 4-6 % (16), with the risks of complications decreasing with age. Stones within Meckel's diverticulum are recognized as a rare complication in the adult population (13,15). However, it has not been reported in the pediatric age group. The authors describe a 19-month-old male who presented with intermittent abdominal pain and vomiting, chronic microcytic anemia and a calcified stone in the lower abdomen, who was found to have a Meckel's enterolith.     

抑肽酶对大鼠血肿周围脑组织炎症反应和细胞凋亡的影响

目的 通过抑肽酶干预,研究大鼠血肿周围脑组织炎症和细胞凋亡的关系,以探讨脑出血后继发性损伤的机制.方法 采用立体定向手术脑尾状核胶原酶注射诱导大鼠脑出血模型,用抑肽酶进行干预,于不同时相点测定TUNEL阳性细胞,用组织病理学HE染色观察不同时相点的炎症浸润情况,用免疫组织化学测定IL-1β的蛋白表达水平.结果 模型组TUNEL阳性细胞造模后6h即出现,24h明显增加,3d达到高峰,7d时仍有较多表达;HE染色见6h血肿内及周围有少量散在白细胞,24h明显增加,48h到高峰,3d时稍减少,7d时仍有较多的白细胞浸润.模型组血肿周围脑组织的IL-1β阳性细胞数在6h即有增加,48h左右达高峰;抑肽酶组与模型组比较,TUNEL阳性细胞在24h、48h、72h时明显减少(P＜0.01);HE染色可见浸润白细胞数目在24h、48h、72h时明显减少(P＜0.01).抑肽酶组IL-1β相应各时间点的阳性表达明显减少,尤以48h、72h较为明显.结论抑肽酶能明显抑制脑出血后的炎症反应和细胞凋亡;而抑制炎症反应很可能是减少脑出血神经细胞凋亡的有效途径之一.     

缺氧／复氧对兔肾动脉内皮依赖性舒张功能的影响

目的 探讨缺氧／复氧对肾动脉内皮依赖性一氧化氮(NO)和内皮衍性超极化因子(EDHF)途径舒张功能的影响。方法 采用器官槽法，以兔肾动脉环为研究对象，首先抑制PGI2舒张途径，然后再分别抑制NO和EDHF舒张途径，对给与血管环以缺氧／复氧处理，观察缺氧／复氧分别对NO和EDHF舒张途径的影响。结果 缺氧／复氧使NO途径的内皮依赖性舒张功能减退．而缺氧／复氧对EDHF途径的内皮依赖性舒张功能无变化。结论 缺氧／复氧导致兔肾血管内皮衍性NO途径的舒张损伤．而对EDHF途径的舒张无影响。